Inactive Instrument
Isodiol International Inc. Stock Canadian Securities Exchange
Stocks
ISOL
CA46500L2003
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.91M 2.82M 2.43M 2.28M 2.08M 268M 3.94M 27.03M 10.52M 136M 10.59M 10.36M 451M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.59M 5.67M 5.33M 4.86M 627M 9.2M 63.11M 24.56M 318M 24.74M 24.2M 1.05B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | +16.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 2017-05-23 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 2018-08-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 2017-05-23 |
| Director/Board Member | - | 2018-08-29 | |
| Director/Board Member | - | 2018-11-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +16.67% | +40.00% | - | - | 128 | |
| +0.78% | +2.15% | -12.49% | -6.96% | 13.26B | |
| -2.41% | +0.50% | -33.04% | -56.86% | 4.99B | |
| -3.11% | -1.57% | -8.27% | -7.32% | 4.66B | |
| -1.55% | -3.16% | -2.75% | -31.25% | 4.02B | |
| -1.07% | +1.95% | -21.84% | +3.65% | 3.59B | |
| +3.31% | +6.11% | +0.23% | -0.92% | 3.43B | |
| -1.41% | -1.94% | -11.14% | +5.99% | 3.31B | |
| -1.65% | -3.87% | -23.53% | -14.45% | 2.38B | |
| -1.52% | +1.41% | -27.89% | -15.73% | 1.72B | |
| Average | +0.80% | -0.38% | -15.63% | -13.76% | 4.6B | |
| Weighted average by Cap. | -0.63% | -0.19% | -14.47% | -13.72% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.8M 11.89M 11.16M 10.19M 1.31B 19.27M 132M 51.45M 666M 51.83M 50.7M 2.21B | 22.25M 16.05M 13.82M 12.97M 11.84M 1.53B 22.41M 154M 59.82M 774M 60.25M 58.95M 2.56B |
| Net income | -36.02M -25.98M -22.37M -21.01M -19.17M -2.47B -36.28M -249M -96.84M -1.25B -97.56M -95.44M -4.15B | -126M -90.82M -78.2M -73.43M -67.03M -8.64B -127M -870M -339M -4.38B -341M -334M -14.51B |
| Net Debt | -15.55M -11.22M -9.66M -9.07M -8.28M -1.07B -15.66M -107M -41.81M -541M -42.11M -41.2M -1.79B | 5.22M 3.77M 3.24M 3.05M 2.78M 358M 5.26M 36.09M 14.04M 182M 14.14M 13.84M 602M |
Employees
-
Sector
Pharmaceuticals
